Popular Trials
Behavioral Intervention
Mind-Body Skills for Chronic Pain
Recruiting1 award1 criteria
Minneapolis, Minnesota
This trial aims to study non-medication pain management for Veterans in rural areas with chronic pain. They will conduct a pilot study with 40 patients to see if the treatment delivery is possible and effective for
Procedure
Cardiopulmonary Exercise for Congenital Heart Disease
Recruiting1 award2 criteria
Rochester, Minnesota
This trial aims to see if we can better detect heart problems by comparing tests done at rest and during exercise. We also want to see how well different tests correlate with each other and if they can help
Popular Filters
Phase 3 Trials
Monoclonal Antibodies
Zanidatamab vs Trastuzumab for Breast Cancer
Recruiting2 awardsPhase 3
Coon Rapids, Minnesota
This trial will test a new drug called zanidatamab in combination with chemotherapy to see if it is better than the current standard treatment using trastuzumab and chemotherapy for patients with
Trials With No Placebo
Women with > 3 months amenorrhea for Hypogonadism
Recruiting1 award10 criteria
Rochester, Minnesota
The purpose of this study is to to build a registry of women with early estrogen loss due to Functional Hypothalamic Amenorrhea (FHA) to understand the prevalence, racial and ethnic diversity of this condition.
Study group for Breast Cancer
Recruiting1 award6 criteria
Minneapolis, Minnesota
Breast cancer is the second most common cancer in women. One in five women who have been treated for breast cancer develop lymphedema. Lymphedema is a very common result of breast cancer and its treatment. Lymphedema is the build-up of fluid in tissues, which results in tissue swelling. The lymph system is a network of lymph vessels, tissues, and organs that carry extra fluid from your cells/tissues throughout the body. If this lymph fluid is not able to flow in the body how it should, there will be swelling which can lead to lymphedema. It can be classified into stages 0 to 3 depending on the severity of the condition. Stages 0 and 1 are reversible, and through early diagnosis and treatment, the recovery to the normal volume and normal skin status of arms can be possible. On the other hand, stage 2 or higher is irreversible, and tissue fibrosis progresses and cannot return to normal skin; therefore, it is important to detect early and start treatment. This is an observational longitudinal study. Potential participants will be recruited for follow-up after breast cancer surgery. Only patients who fit the inclusion criteria will be considered for participation in the study and contacted by the healthcare provider. Standard of care will be used to guide any treatment needed by participants while they are part of the study.
Behavioural Intervention
Personalized Feedback for Substance Use Disorder
Recruiting1 award
Minneapolis, Minnesota
"This trial aims to understand what triggers substance use and how to manage those triggers. Researchers will create personalized models to show how substance use, urges, and other symptoms like anxiety and depression are connected. They
Patients who are completing an outpatient electrocardiogram (ECG) at the Mayo Clinic. for Aortic Stenosis
Recruiting1 award1 criteria
Rochester, Minnesota
Two recently developed artificial intelligence-enabled electrocardiogram (AI-ECG) models have been developed to detect aortic stenosis (AS) and diastolic dysfunction (DD). AI-ECG for AS has a sensitivity of 78% and specificity of 74%, and AI-ECG for DD has a sensitivity of 83% and specificity of 80%. However, these models have never been prospectively applied to diagnose AS or DD, which may be useful for patients and providers from a diagnostic and prognostic perspective and especially in settings where access to higher- level medical care is limited. In this study, we aim to determine the clinical utility of these AI-ECG models by prospectively applying them to an outpatient cohort and then completing a focused point-of-care ultrasound to evaluate those who are AI-ECG positive for AS and DD.
Behavioural Intervention
End-Tidal Oxygen Monitoring for Preventing Hypoxia
Recruiting1 award3 criteria
Minneapolis, Minnesota
"This trial evaluates whether using end-tidal oxygen levels can help prevent low oxygen levels during intubation in the emergency department. It is a high-risk procedure where patients are given extra oxygen before intub
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.